HomeLEXX • NASDAQ
add
Lexaria Bioscience Corp
Previous close
$2.97
Day range
$2.92 - $3.11
Year range
$0.85 - $6.85
Market cap
46.48M USD
Avg Volume
189.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | May 2024info | Y/Y change |
|---|---|---|
Revenue | 84.00K | 8.10% |
Operating expense | 1.83M | -25.91% |
Net income | -1.78M | 24.87% |
Net profit margin | -2.12K | 30.50% |
Earnings per share | — | — |
EBITDA | -1.73M | 27.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | May 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.51M | 147.72% |
Total assets | 10.02M | 91.20% |
Total liabilities | 271.38K | -77.36% |
Total equity | 9.75M | — |
Shares outstanding | 15.81M | — |
Price to book | 4.64 | — |
Return on assets | -53.23% | — |
Return on capital | -53.84% | — |
Cash Flow
Net change in cash
| (USD) | May 2024info | Y/Y change |
|---|---|---|
Net income | -1.78M | 24.87% |
Cash from operations | -1.27M | 29.11% |
Cash from investing | -22.00K | 34.61% |
Cash from financing | 5.04M | 194.67% |
Net change in cash | 3.75M | 3,569.34% |
Free cash flow | -980.21K | 2.68% |
About
Founded
2004
Website
Employees
5
